Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets

Oncogene

Volumn 31, Issue 18, 2012, Pages 2258-2269

  Berardi, S ^a   Caivano, A ^b   Ria, R ^a   Nico, B ^a   Savino, R ^c   Terracciano, R ^c   De Tullio, G ^a   Ferrucci, A ^a   De Luisi, A ^a   Moschetta, M ^a   Mangialardi, G ^d   Catacchio, I ^a   Basile, A ^a   Guarini, A ^e   Zito, A ^f   Ditonno, P ^f   Musto, P ^b   Dammacco, F ^a   Ribatti, D ^a   Vacca, A ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^f DI VENERE HOSPITAL   (Italy)

Author keywords

angiogenesis; antiangiogenesis; endothelial cells; multiple myeloma; proteomic analysis

Indexed keywords

ALPHA CRYSTALLIN; BORTEZOMIB; FILAMIN A; LENALIDOMIDE; PANOBINOSTAT; PROTEIN 14 3 3; VIMENTIN;

ADULT; AGED; ANEMIA; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL MIGRATION; CELL SPREADING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG TARGETING; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MORPHOGENESIS; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEOMICS;

14-3-3 PROTEINS; AGED; AGED, 80 AND OVER; ALPHA-CRYSTALLINS; ANEMIA; BONE MARROW CELLS; CELL MOVEMENT; CONTRACTILE PROTEINS; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; MOLECULAR TARGETED THERAPY; MULTIPLE MYELOMA; NEOVASCULARIZATION, PATHOLOGIC; PARAPROTEINEMIAS; PROTEOMICS; VIMENTIN;

EID: 84861348702     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.412     Document Type: Article

References (49)

1. Aird WC. (2007). Phenotypic heterogeneity of the endothelium. Circ Res 100: 174-190.
2. Aitken A. (2006). 14-3-3 proteins: a historic overview. Semin Cancer Biol 16: 162-172. (Pubitemid 43796128)
3. Andley UP. (2007). Crystallins in the eye: Function and pathology. Prog Retin Eye Res 26: 78-98. (Pubitemid 44894995)
4. Arrigo AP, Simon S, Gibert B, Kretz-Remy C, Nivon M, Czekalla A ,et al. (2007). Hsp27 (HspB1) and aB-crystallin (HspB5) as therapeutic targets. FEBS Lett 581: 3665-3674. (Pubitemid 47086314)
5. Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM ,et al. (2009). Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res 15: 788-796.
6. Chan W, Kozma R, Yasui Y, Inagaki M, Leung T, Manser E ,et al. (2002). Vimentin intermediate filament reorganization by Cdc42: involvement of PAK and p70 S6 kinase. Eur J Cell Biol 81: 692-701. (Pubitemid 36104764)
7. Coluccia AML, Cirulli T, Neri P, Mangieri D, Colanardi MC, Gnoni A ,et al. (2008). Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib. Blood 112: 1346-1356.
8. De Luisi A, Ferrucci A, Coluccia AML, Ria R, Moschetta M, De Luca E ,et al. (2011). Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma. Clin Cancer Res 17: 1935-1946.
9. Dimberg A, Rylova S, Dieterich LC, Olsson AK, Schiller P, Wikner C ,et al. (2008). alphaB-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis. Blood 111: 2015-2023. (Pubitemid 351451512)
10. Dutsch-Wicherek M. (2010). RCAS1, MT, and vimentin as potential markers of tumor microenvironment remodeling. Am J Reprod Immunol 63: 181-188.
11. Eriksson JE, Dechat T, Grin B, Helfand B, Mendez M, Pallari HM ,et al. (2009). Introducing intermediate filaments: from discovery to disease. J Clin Invest 119: 1763-1771.
12. Fan T, Li R, Todd NW, Qiu Q, Fang HB, Wang H ,et al. (2007). Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res 67: 7901-7906. (Pubitemid 47281386)
13. Feng Y, Chen MH, Moskowitz IP, Mendonza AM, Vidali L, Nakamura F ,et al. (2006). Filamin A (FLNA) is required for cellcell contact in vascular development and cardiac morphogenesis. Proc Natl Acad Sci USA 103: 19836-19841. (Pubitemid 46037517)
14. Ge F, Lu XP, Zeng HL, He QY, Xiong S, Jin L ,et al. (2009). Proteomic and functional analyses reveal a dual molecular mechanism underlying arsenic-induced apoptosis in human multiple myeloma cells. J Proteome Res 8: 3006-3019.
15. Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, Foidart JM ,et al. (1999). Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 112: 4615-4625. (Pubitemid 30034810)
16. Gonzales M, Weksler B, Tsuruta D, Goldman RD, Yoon KJ, Hopkinson SB ,et al. (2001). Structure and function of a vimentinassociated matrix adhesion in endothelial cells. Mol Biol Cell 12: 85-100. (Pubitemid 32060580)
17. Gruvberger Saal SK, Parsons R. (2006). Is the small heat shock protein aB-crystallin an oncogene? J Clin Invest 116: 30-32. (Pubitemid 43121787)
18. Head MW, Hurwitz L, Kegel K, Goldman JE. (2000). AlphaBcrystallin regulates intermediate filament organization in situ. Neuroreport 11: 361-365. (Pubitemid 30074650)
19. Hellebrekers DM, Castermans K, Viré E, Dings RP, Hoebers NT, Mayo KH ,et al. (2006). Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications. Cancer Res 66: 10770-10777. (Pubitemid 44876972)
20. Hishiya A, Takayama S. (2008). Molecular chaperones as regulators of cell death. Oncogene 27: 6489-6506.
21. Kamradt MC, Chen F, Cryns VL. (2001). The small heat shock protein alpha B-crystallin negatively regulates cytochrome c-and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J Biol Chem 276: 16059-16063.
22. Kase S, He S, Sonoda S, Kitamura M, Spee C, Wawrousek E ,et al. (2010). AlphaB-crystallin regulation of angiogenesis by modulation of VEGF. Blood 115: 3398-3406.
23. Kim H, Nakamura F, Lee W, Shifrin Y, Arora P, McCulloch CA. (2010). Filamin A is required for vimentin-mediated cell adhesion and spreading. Am J Physiol Cell Physiol 298: C221-C236.
24. Kuehl WM, Bergsagel PL. (2002). Multiple myeloma: evolving genetics events and host interactions. Nat Rev Cancer 2: 175-187. (Pubitemid 37328787)
25. Lee JW, Kwak HJ, Lee JJ, Kim YN, Lee JW, Park MJ ,et al. (2008). HSP27 regulates cell adhesion and invasion via modulation of focal adhesion kinase and MMP-2 expression. Eur J Cell Biol 87: 377-387.
26. Li Z, Zhao J, Du Y, Park HR, Sun S-Y, Bernal-Mizrachi L ,et al. (2008). Down-regulation of 14-3-3z suppresses anchorage independent growth of lung cancer cells through anoikis activation. Proc Natl Acad Sci USA 105: 162-167.
27. Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Method Methods 25: 402-408. (Pubitemid 34164012)
28. Lu CH, Ge F, Liu Z, Li R, Xiao CL, Zeng HL ,et al. (2010). Detection of abundant proteins in multiple myeloma cells by proteomics. J Proteomics Bioinformatics 3: 5-9.
29. Maiso P, Carvajal-Vergara X, Ocio EM, Ló pez-Pérez R, Mateo G, Gutiérrez N ,et al. (2006). The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance. Cancer Res 66: 5781-5789. (Pubitemid 43927132)
30. Matrone MA, Whipple RA, Balzer EM, Martin SS. (2010). Microtentacles tip the balance of cytoskeletal forces in circulating tumor cells. Cancer Res 70: 7737-7741.
31. Meriane M, Mary S, Comunale F, Vignal E, Fort P, Gauthier-Rouviére C. (2010). Cdc42Hs and Rac1 GTPases induce the collapse of the vimentin intermediate filament network. J Biol Chem 275: 33046-33052.
32. Morrison DK. (2009). The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol 19: 16-23.
33. Moyano JV, Evans JR, Chen F, Lu M, Werner ME, Yehiely F ,et al. (2006). aB-Crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest 116: 261-270. (Pubitemid 43121811)
34. Obermeyer N, Janson N, Bergmann J, Buck F, Ito WD. (2003). Proteome analysis of migrating versus nonmigrating rat heart endothelial cells reveals distinct expression patterns. Endothelium 10: 167-178. (Pubitemid 37270744)
35. Podar K, Tai YT, Davies FE, Lentzsch S, Sattler M, Hideshima T ,et al. (2001). Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration. Blood 98: 428-435.
36. Popowicz GM, Schleicher M, Noegel AA, Holak TA. (2006). Filamins: promiscuous organizers of the cytoskeleton. Trends Biochem Sci 31: 411-419. (Pubitemid 44038918)
37. Ria R, Todoerti K, Berardi S, Coluccia AML, De Luisi A, Mattioli M ,et al. (2009). Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma. Clin Cancer Res 15: 5369-5378.
38. Ribatti D, Nico B, Vacca A. (2006). Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene 25: 4257-4266. (Pubitemid 44100496)
39. Roccaro AM, Hideshima T, Raje N, Kumar S, Ishitsuka K, Yasui H ,et al. (2006). Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells. Cancer Res 66: 184-191. (Pubitemid 43166024)
40. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. (2006). In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1: 2856-2860.
41. Sluchanko NN, Chernik IS, Seit-Nebi AS, Pivovarova AV, Levitsky DI, Gusev NB. (2008). Effect of mutations mimicking phosphorylation on the structure and properties of human 14-3-3zeta. Archiv Biochem Biophys 477: 305-312.
42. Tsuruta D, Jones JC. (2003). The vimentin cytoskeleton regulates focal contact size and adhesion of endothelial cells subjected to shear stress. J Cell Sci 116: 4977-4984. (Pubitemid 38016704)
43. Vacca A, Ria R, Semeraro F, Merchionne F, Coluccia M, Boccarelli A ,et al. (2003). Endothelial cells in the bone marrow of patients with multiple myeloma. Blood 102: 3340-3348. (Pubitemid 37314776)
44. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F ,et al. (1994). Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 87: 503-508. (Pubitemid 24230014)
45. Vadlamudi RK, Li F, Adam L, Nguyen D, Ohta Y, Stossel TP ,et al. (2002). Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1. Nat Cell Biol 4: 681-690. (Pubitemid 34993704)
46. Van den IJssel P, Wheelock R, Prescott A, Russell P, Quinlan RA. (2003). Nuclear speckle localisation of the small heat shock protein alpha B-crystallin and its inhibition by the R120G cardiomyopathylinked mutation. Exp Cell Res 287: 249-261. (Pubitemid 37323839)
47. Van Rijk AE, Stege GJ, Bennink EJ, May A, Bloemendal H. (2003). Nuclear staining for the small heat shock protein alphaBcrystallin colocalizes with splicing factor SC35. Eur J Cell Biol 82: 361-368. (Pubitemid 36944165)
48. Zhou AX, Hartwig JH, Akyü rek LM. (2010). Filamins in cell signaling, transcription and organ development. Trends Cell Biol 20: 113-123.
49. Wang Z, Tropè CG, Suo Z, Tren G, Yang G, Nesland JM ,et al. (2008). The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas. BMC Cancer 10: 1186/1471-2407-8-308.